SCPH Company Profile and Key Details

Q: Who are the executives of SCPH?

Mr. Michael D. HassmanSenior Vice President of Technical OperationsSteve ParsonsSenior Vice President of CommercialDr. John Mohr Pharm.D.Senior Vice President of Clinical Devel. & Medical AffairsKatherine TaudvinVice President of Corporation Affairs & HRMs. Rachael NokesChief Financial Officer & Principal Accounting OfficerMr. John H. TuckerPres, Chief Executive Officer, Principal Executive Officer, Principal Financial Officer & Director

NASDAQ : SCPH

scPharmaceuticals

$5.67

Open: 4:00 PM

Not Actively Trading

67.94

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

scPharmaceuticals Inc. (SCPH) stock remained unchanged at $5.67 a share on NASDAQ. The stock opened at $5.67, fluctuating between $5.67 to $5.67 during the session.

Stock Snapshot

5.67

Prev. Close

302.2M

Market Cap

5.67

Day Low

-3.132596685082873

P/E Ratio

-1.81

EPS (TTM)

-1.53

Cash Flow per Share

5.67

Open

53.3M

Number of Shares

5.67

Day High

65.24%

Free Float in %

0.96

Book Value

10.9M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Oct 06, 2025	5.68	5.71	5.65	5.67	10.88M
Oct 03, 2025	5.66	5.68	5.66	5.67	3.81M
Oct 02, 2025	5.65	5.67	5.64	5.66	1.01M
Oct 01, 2025	5.67	5.67	5.65	5.66	2.69M
Sep 30, 2025	5.67	5.69	5.65	5.67	1.91M
Sep 29, 2025	5.65	5.69	5.63	5.67	1.65M
Sep 26, 2025	5.63	5.65	5.62	5.65	860.22K
Sep 25, 2025	5.63	5.63	5.61	5.61	1.08M
Sep 24, 2025	5.63	5.65	5.62	5.63	569.26K
Sep 23, 2025	5.63	5.64	5.61	5.64	1.05M
Sep 22, 2025	5.61	5.64	5.61	5.63	670.28K
Sep 19, 2025	5.63	5.64	5.61	5.63	1.63M
Sep 18, 2025	5.63	5.65	5.61	5.62	1.55M
Sep 17, 2025	5.63	5.65	5.62	5.63	1.22M
Sep 16, 2025	5.62	5.65	5.61	5.62	944.58K
Sep 15, 2025	5.62	5.63	5.61	5.61	846.8K
Sep 12, 2025	5.62	5.64	5.61	5.63	412.21K
Sep 11, 2025	5.61	5.64	5.61	5.63	2M
Sep 10, 2025	5.62	5.64	5.61	5.61	846.38K
Sep 09, 2025	5.57	5.63	5.57	5.62	728.76K

Contact Details

Burlington, MA 01803

United States

https://www.scpharmaceuticals.com 617 517 0730

About Company

scPharmaceuticals Inc. is a pharmaceutical firm dedicated to developing and commercializing a variety of medicinal products. Its primary investigational therapy, FUROSCIX, is a specialized formulation of furosemide delivered through an on-body infusor, intended for managing congestion in heart failure patients. The company's pipeline also encompasses scCeftriaxone, an antibiotic aimed at treating infections caused by both gram-positive and gram-negative bacteria, as well as the scCarbapenem program, another antibiotic designed for gram-negative bacterial infections. Additionally, scPharmaceuticals has entered into a collaboration agreement with West Pharmaceutical Services, Inc. for the advancement of a single-use SmartDose device. Founded in 2013, the company's main operations are based in Burlington, Massachusetts.

Stock Peers

ARGX

0.35+0.04%

argenx SE$984.39 REGN

-11.77-1.48%

Regeneron Pharmaceuticals, Inc.$781.49 MDGL

1.37+0.26%

Madrigal Pharmaceuticals, Inc.$534.49 VRTX

0.88+0.17%

Vertex Pharmaceuticals Incorporated$515.44 UTHR

-6.75-1.34%

United Therapeutics Corporation$497.11 KRYS

1.45+0.42%

Krystal Biotech, Inc.$347.00 ONC

4.71+1.38%

BeOne Medicines AG$346.51 PRAX

-3.99-1.18%

Praxis Precision Medicines, Inc.$334.58 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

-4.78-1.65%

Ligand Pharmaceuticals Incorporated$284.47

Frequently Asked Questions

What is the current scPharmaceuticals Inc. (SCPH) stock price?

scPharmaceuticals Inc. (NASDAQ: SCPH) stock price is $5.67 in the last trading session. During the trading session, SCPH stock reached the peak price of $5.67 while $5.67 was the lowest point it dropped to. The percentage change in SCPH stock occurred in the recent session was 0% while the dollar amount for the price change in SCPH stock was $0.00.

SCPH's industry and sector of operation?

The NASDAQ listed SCPH is part of Biotechnology industry that operates in the broader Healthcare sector. scPharmaceuticals Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of SCPH?

Mr. Michael D. Hassman
Senior Vice President of Technical Operations
Steve Parsons
Senior Vice President of Commercial
Dr. John Mohr Pharm.D.
Senior Vice President of Clinical Devel. & Medical Affairs
Katherine Taudvin
Vice President of Corporation Affairs & HR
Ms. Rachael Nokes
Chief Financial Officer & Principal Accounting Officer
Mr. John H. Tucker
Pres, Chief Executive Officer, Principal Executive Officer, Principal Financial Officer & Director

How SCPH did perform over past 52-week?

SCPH's closing price is 192.27% higher than its 52-week low of $1.94 where as its distance from 52-week high of $6.28 is -9.71%.

How many employees does SCPH have?

Number of SCPH employees currently stands at 162.

Link for SCPH official website?

Official Website of SCPH is: https://www.scpharmaceuticals.com

How do I contact SCPH?

SCPH could be contacted at phone 617 517 0730 and can also be accessed through its website. SCPH operates from 2400 District Avenue, Burlington, MA 01803, United States.

How many shares of SCPH are traded daily?

SCPH stock volume for the day was 10.9M shares. The average number of SCPH shares traded daily for last 3 months was 1.45M.

What is the market cap of SCPH currently?

The market value of SCPH currently stands at $302.20M with its latest stock price at $5.67 and 53.3M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	162
Beta	0.3
Sales or Revenue	$13.59M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	162
Beta	0.3
Sales or Revenue	$13.59M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

SCPH Company Profile and Key Details

scPharmaceuticals

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Company Overview

Earnings & Analyst Outlook

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Valuation Metrics